Ann: Change in substantial holding, page-20

While the share price has been disappointing, largely due to IDT being screwed over by the government, they company's washing it's face with its cannabis business, is trading well under replacement value of land and plant and has a sizeable spare capacity. While it made tremendous sense that the company would be supported by the government under national interest issues, to bring the manufacture of medicines (not just Covid vaccines) needed by Australians to Australia, the patience of management must be just as frayed as investors waiting for this to happen. When the board and management reach a turning point, IDT can surely look to source the funds and strategic partnerships it needs from the corporate world globally. This company is more than a one trick pony.